These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2452112)

  • 21. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].
    Hirakata M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():555-9. PubMed ID: 20942128
    [No Abstract]   [Full Text] [Related]  

  • 23. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.
    Marguerie C; Bunn CC; Beynon HL; Bernstein RM; Hughes JM; So AK; Walport MJ
    Q J Med; 1990 Oct; 77(282):1019-38. PubMed ID: 2267280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
    Mahler M; Miller FW; Fritzler MJ
    Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.
    Fudman EJ; Schnitzer TJ
    Semin Arthritis Rheum; 1986 May; 15(4):255-60. PubMed ID: 3520822
    [No Abstract]   [Full Text] [Related]  

  • 26. Polydermatomyositis with anti-PL7 antibody: clinical and laboratory follow-up over a five year period.
    Walker EJ; Jeffrey PD; Webb J; Tymms KE
    Clin Exp Rheumatol; 1989; 7(5):537-40. PubMed ID: 2591129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Idiopathic Inflammatory Myopathy and Anti-aminoacyl-tRNA Synthetase Antibody].
    Maeda MH
    Brain Nerve; 2018 Apr; 70(4):439-448. PubMed ID: 29632291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
    Tsui FW; Siminovitch KA
    Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
    Walker EJ; Tymms KE; Webb J; Jeffrey PD
    J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Threonyl-tRNA synthetase.
    Freist W; Gauss DH
    Biol Chem Hoppe Seyler; 1995 Apr; 376(4):213-24. PubMed ID: 7626230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Threonyl-tRNA synthetase gene maps close to leucyl-tRNA synthetase gene on human chromosome 5.
    Gerken SC; Wasmuth JJ; Arfin SM
    Somat Cell Mol Genet; 1986 Sep; 12(5):519-22. PubMed ID: 3464105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and structural characterization of rat liver threonyl transfer ribonucleic acid synthetase.
    Dignam JD; Rhodes DG; Deutscher MP
    Biochemistry; 1980 Oct; 19(22):4978-84. PubMed ID: 7459319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
    Dang CV; LaDuca FM; Bell WR
    Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Threonyl-tRNA synthase from rabbit reticulocytes: a reversible transition from the RNA-non-binding to the RNA-binding form].
    Fedorov AN; Riazanov AG; Ovchinnikov LP
    Biokhimiia; 1986 Sep; 51(9):1541-8. PubMed ID: 2429710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two human tRNA(Ala) families are recognized by autoantibodies in polymyositis sera.
    Bunn CC; Mathews MB
    Mol Biol Med; 1987 Feb; 4(1):21-36. PubMed ID: 3613974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese hamster ovary cells resistant to borrelidin overproduce threonyl-tRNA synthetase.
    Gerken SC; Arfin SM
    J Biol Chem; 1984 Jul; 259(14):9202-6. PubMed ID: 6746646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies.
    Fahoum SK; Yang DC
    Biochemistry; 1987 Sep; 26(18):5871-7. PubMed ID: 3499936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B; Devilliers H; Benveniste O
    Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
    [No Abstract]   [Full Text] [Related]  

  • 39. Autogenous repression of Escherichia coli threonyl-tRNA synthetase expression in vitro.
    Lestienne P; Plumbridge JA; Grunberg-Manago M; Blanquet S
    J Biol Chem; 1984 Apr; 259(8):5232-7. PubMed ID: 6325425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis].
    Kinoshita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():482-4. PubMed ID: 2355568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.